Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M23,828Revenue $M2,881Net Margin (%)10.3Z-Score1.4
Enterprise Value $M34,429EPS $0.3Operating Margin %10.2F-Score7
P/E(ttm))81.7Cash Flow Per Share $3.6Pre-tax Margin (%)9.6Higher ROA y-yY
Price/Book2.010-y EBITDA Growth Rate %0Quick Ratio2.6Cash flow > EarningsY
Price/Sales6.65-y EBITDA Growth Rate %9.2Current Ratio2.6Lower Leverage y-yY
Price/Cash Flow16.9y-y EBITDA Growth Rate %17.5ROA % (ttm)1.4Higher Current Ratio y-yY
Dividend Yield %4.4Insider Buy (3m)1ROE % (ttm)2.8Less Shares Outstanding y-yN
Payout Ratio %401Shares Outstanding M309ROI % (ttm)-1.2Gross Margin Increase y-yN

Gurus Latest Trades with HCN

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
HCNRay Dalio 2014-09-30 Sold Out -0.09%$61.92 - $68.32
($64.55)
$ 72.7213%Sold Out0
HCNRay Dalio 2014-03-31 Reduce-0.07%$53.05 - $59.87
($56.98)
$ 72.7228%Reduce -46.65%173,893
HCNRay Dalio 2013-12-31 Add0.13%$52.58 - $66.47
($59.5)
$ 72.7222%Add 1764.14%325,964
HCNRay Dalio 2013-09-30 Buy 0.01%$58.32 - $68.6
($63.58)
$ 72.7214%New holding, 17486 sh.17,486
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

HCN is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
HCN Ray Dalio 2014-09-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


HCN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ESTES SCOTT AEVP and CFO 2014-11-17Sell3,000$71.891.15view
HERMAN CHARLES J JREVP/Pres, Srs. Hous/Post Acute 2014-11-10Sell1,000$70.892.58view
Brinker Scott MEVP - Chief Investment Officer 2014-11-07Sell4,286$70.842.65view
CRABTREE MICHAEL ASr. Vice President & Treasurer 2014-11-05Sell1,000$72.140.8view
IBELE ERIN CEVP-Head Human Cap.&Corp.Secy. 2014-10-20Sell175$66.898.72view
IBELE ERIN CEVP-Head Human Cap.&Corp.Secy. 2014-10-15Sell779$67.328.02view
ESTES SCOTT AEVP and CFO 2014-10-15Sell3,000$67.328.02view
HERMAN CHARLES J JREVP/Pres, Srs. Hous/Post Acute 2014-10-10Sell1,000$66.469.42view
IBELE ERIN CEVP-Head Human Cap.&Corp.Secy. 2014-10-09Sell175$6511.88view
CRABTREE MICHAEL ASr. Vice President & Treasurer 2014-10-06Sell1,000$63.0415.36view

Press Releases about HCN :

    Quarterly/Annual Reports about HCN:

    News about HCN:

    Articles On GuruFocus.com
    Dividend Aristocrats In Focus Part 43: The Only REIT In The Dividend Aristocrats Index Nov 22 2014 
    GuruFocus Names Top Five Dividend Growers of the Week Nov 03 2014 
    GuruFocus Names Four Dividend Growers May 05 2014 
    Health Care REIT: HCN Combines Megatrends and Dividends Feb 14 2014 
    GuruFocus Reports Nine Dividend Growers Feb 04 2014 
    Howard Marks Makes Major Construction Buy, 8 Others in Q3 Nov 11 2013 
    Thomson Reuters and Chevron Highlight GuruFocus' Top Dividend Growers of the Week Nov 04 2013 
    GuruFocus Names Ten Dividend Growers: July 22 to 26 Jul 29 2013 
    My 3 Favorite Safe Stocks from the Financial Sector Apr 10 2013 
    My 3 Favorite Financial Dividend Stocks with Double-Digit Earnings Growth Feb 09 2013 


    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK